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Available online 13 November 2006AbstractOxidative stress has been implicated in the pathogenesis and progression of neurodegenerative disorders and antioxidants potentially have a
major role in neuroprotection. Optimum levels of glutathione (g-glutamylcysteinyl glycine), an endogenous thiol antioxidant are required for the
maintenance of the redox status of cells. Cystathionine g-lyase is the rate-limiting enzyme for the synthesis of cysteine from methionine and
availability of cysteine is a critical factor in glutathione synthesis. In the present study, we have examined the role of cystathionine g-lyase in
maintaining the redox homeostasis in brain, particularly with reference to mitochondrial function since the complex I of the electron transport
chain is sensitive to redox perturbation. Inhibition of cystathionine g-lyase by L-propargylglycine caused loss of glutathione and decrease in
complex I activity in the brain although the enzyme activity in mouse brain was 1% of the corresponding hepatic activity. We then examined the
effect of this inhibition on the neurotoxicitymediated by the excitatory amino acid, L-b-oxalyl amino-L-alanine, which is the causative factor of a
type of motor neuron disease, neurolathyrism. L-b-Oxalyl amino-L-alanine toxicity was exacerbated by L-propargylglycine measured as loss of
complex I activity indicating the importance of cystathionine g-lyase in maintaining glutathione levels and in turn the mitochondrial function
during excitotoxicity. Oxidative stress generated by L-b-oxalyl amino-L-alanine itself inhibited cystathionine g-lyase, which could be prevented
by prior treatment with thiol antioxidant. Thus, cystathionine g-lyase itself is susceptible to inactivation by oxidative stress and this can
potentially exacerbate oxidant-induced damage. Cystathionine g-lyase is present in neuronal cells in human brain and its activity is several-fold
higher compared to mouse brain. It could potentially play an important role in maintaining glutathione and protein thiol homeostasis in brain and
hence afford neuroprotection.
# 2006 Elsevier Ltd. All rights reserved.
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protein thiol is present in millimolar amounts in mammalian
cells. GSH is less prone to oxidation than cysteine and is ideal
for maintaining intracellular redox potential. It exists pre-
dominantly in the reduced (thiol, GSH) form and the oxidized
(disulfide, GSSG) form accounts for less than 1% of the total
glutathione. In the cell, almost 90–95% of glutathione is in the
cytosol, about 5% in the mitochondria and a small percentage in
the endoplasmic reticulum and in the nucleus (Meister, 1991).
Important functions of GSH include its antioxidant activity (Lu,
1999), specifically its role in maintaining protein thiol* Corresponding author. Tel.: +91 124 233 8929; fax: +91 124 233 8928.
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doi:10.1016/j.neuint.2006.09.014homeostasis, reaction partner for the detoxification of
xenobiotics (Rahman et al., 1999), cofactor in isomerization
reactions (Dringen et al., 2000) and as storage and transport
form of cysteine (Lu, 1999). In brain, GSH is an important
antioxidant since brain is highly sensitive to perturbation in the
equilibrium between antioxidant system and reactive oxygen
species (Clarke and Sokolof, 1999). Oxidative stress has been
implicated in the pathogenesis and progression of several
neurodegenerative diseases (Bains and Shaw, 1997) and
maintenance of redox status as well as the antioxidant
capability of CNS during oxidative stress is vital for
neuroprotection.
GSH is synthesized from cysteine, glutamate and glycine by
the consecutive actions of two cytosolic ATP-dependent
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glutathione synthetase (EC 6.3.2.3) (Meister, 1995). The first
step in GSH biosynthesis is catalyzed by GCS, the rate-limiting
enzyme, while GSH synthetase has apparently no regulatory
role (Lu, 1999). Physiologically, GCS is regulated either by
competitive, nonallosteric inhibition by GSH (Richman and
Meister, 1975) or by the availability of its precursor amino
acids. Availability of cysteine is therefore critical for GSH
synthesis.
Cysteine is synthesized through the transulfuration pathway
wherein dietary methionine is converted to cysteine. ATP-
dependent activation of methionine leads to the production of S-
adenosylmethionine (catalyzed by methionine adenosyltrans-
ferase), and subsequent demethylation and removal of the
adenosyl moiety yields homocysteine. Homocysteine con-
denses with serine to form cystathionine in a reaction catalyzed
by cystathionine b-synthase (using pyridoxal 50 phosphate as
cofactor). The last enzyme of the transsulfuration pathway is
cystathionine g-lyase (CGL, g-cystathionase, EC 4.4.1.1),
which is also a pyridoxal 50 phosphate dependent enzyme. It
catalyzes the conversion of L-cystathionine into L-cysteine, a-
ketobutyrate and ammonia and is the rate-limiting enzyme for
the synthesis of cysteine from methionine. Although, cysteine
levels in cells may also be enhanced by transport of cystine
through specialized transporter systems (Shanker and Aschner,
2001), the importance of the transulfuration pathway in
generating cysteine for GSH synthesis is well recognized in
liver because any perturbation of this pathway leads to
decreased levels of cellular GSH (Meister, 1995). While the
enzyme is well characterized in liver, we have very little
information available on the role of this pathway in the brain
(Heinonen, 1973).
We have examined the constitutive expression of cystathio-
nine g-lyase in brain and studied its role in brain during
excitotoxicity using a model excitatory amino acid, L-BOAA
(L-b-oxalyl amino-L-alanine) present in the chickling pea from
plant Lathyrus sativus (Rao et al., 1964). Consumption of the
chickling peas for prolonged periods leads to a neurodegen-
erative disorder called as neurolathyrism in humans (Selye,
1957) which is manifested by damage of upper motor neurons,
degeneration of anterior horn cells and loss of axons in
pyramidal tracts of lumbar spinal cord (Streifler et al., 1977;
Cohn and Streifler, 1981). L-BOAA exerts neurotoxicity
through the AMPA subclass of glutamate receptors (Pearson
and Nunn, 1981; Ross et al., 1989) and causes inhibition of
mitochondrial complex I (NADH ubiquinone oxidoreductase)
in motor cortex and lumbosacral cord (Sriram et al., 1998) of
mice.
1. Experimental procedures
1.1. Materials
L-BOAA was obtained from Research Biochemicals (Natick, MA). TRI
reagent was purchased fromMolecular Research (Cincinnati, OH). Ubiquinone
1 was obtained as a gift from Eisai Pharmaceutical Company (Tokyo, Japan).
Northern blot analysis was performed using digoxigenin-labeling kit from
Roche Biochemicals (Mannheim, Germany). All other chemicals and reagentswere of analytical grade and were obtained from Sigma Chemical Company (St.
Louis, MO) or Qualigens (Mumbai, India). The plasmid containing cDNA for
cystathionine g-lyase was provided by Dr. Michael Lieberman, Baylor College
of Medicine, Houston, USA.
Human brain tissues were obtained from post-mortem samples of male
traffic accident victims with no known neurological disorders from Human
Brain Tissue Repository for neurobiological studies, Department of Neuro-
pathology, NIMHANS. The average interval between death and autopsy was
8  17 h. The average age of the victims was 28.33  13.35. Human brain
obtained was washed with sterile ice-cold normal saline (sodium chloride,
0.9%, w/v). The meninges and blood vessels were removed from the brain. The
brain regions were dissected out using standard anatomical landmarks. The
brain regions were stored at 70 8C until use.
1.2. Animals
Male Swiss albino mice (3 months old) were obtained from the Animal
Research Facility. Animals had free access to pelleted diet (Lipton Calcutta,
India) and water ad libitum. All animal experiments were carried out according
to National Institutes of Health guidelines for care and use of laboratory
animals. All efforts were made to minimize animal suffering, to reduce number
of animals used and to employ alternatives to in vivo techniques, if available. L-
Propargyl glycine, (cystathionine g-lyase inhibitor; 100 mg/kg body weight)
was administered subcutaneously before L-BOAA and animals were sacrificed
at different time periods after L-BOAA. Control animals received equal volume
of vehicle.
1.3. Processing of tissue
Tissues were processed for measurement of activities of complex I,
cystathionine-g-lyase and estimation of total GSH (GSH + GSSG) levels.
Tissue was homogenized in 0.25 M sucrose and homogenate was centrifuged
at 24,000  g for 30 min to obtain cytosol and used for estimation of cystathio-
nine-g-lyase activity. The homogenate was centrifuged at 1000  g for 10 min
to obtain post-nuclear supernatant. The post-nuclear supernatant was centri-
fuged again at 14,000  g for 30 min to obtain the mitochondrial pellet.
Mitochondrial pellet was suspended in sucrose (0.25 M), and freeze-thawed
for assay of complex I. For assay of GSH, frozen tissue was homogenized in 9
volumes of 100 mM potassium phosphate buffer (pH 7.4) containing 1 mM
EDTA. An aliquot of homogenate was added to an equal volume of 5-
sulfosalicylic acid (10%, w/v), mixed and centrifuged at 10,000  g for
10 min and supernatant was used for estimation of total GSH. Protein con-
centration was estimated by a dye-binding method (Bradford, 1976).
1.4. Estimation of total glutathione
Total glutathione (GSH + GSSG) was estimated by the enzymatic recycling
method (Tietze, 1969). The reaction mixture consisted of 100 mM potassium
phosphate buffer (pH 7.4) containing 0.8 mM dithiobisnitrobenzoic acid and
0.5 U/ml glutathione reductase in a total volume of 0.44 ml. The acid-soluble
tissue supernatant (0.01 ml) prepared as described above was added. The
reaction was initiated by adding 0.05 ml of 1.2 mM NADPH. The increase
in absorbance was measured at 412 nm over 3 min. A standard curve was
generated using known amount of GSSG.
1.5. Assay of NADH:ubiquinone oxido-reductase (complex I) activity
Complex I activity was assayed in mitochondrial preparations as rotenone-
sensitive NADH–ubiquinone oxido-reductase (Sriram et al., 1998; Kenchappa
et al., 2002). The assay was performed in 35 mM potassium phosphate buffer
(pH 7.4) containing sodium cyanide (2.65 mM), magnesium chloride (5 mM),
EDTA (1 mM), bovine serum albumin (1 mg/ml) and antimycin (2 mg/ml).
Brain mitochondria (70–80 mg) and ubiquinone 1 (0.05 mM) were added to the
assay buffer to a final volume of 0.48 ml. After pre-incubation of reaction
mixture at room temperature for 2 min, reaction was initiated by addition
0.02 ml of 5 mMNADH solution. Test and blank reactions were run separately.
The rate of decrease of absorbance at 340 nm was monitored over 3 min. Assay
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enzyme activity and less than 2% of the total activity was rotenone insensitive.
The enzyme activity is expressed as nmoles of NADH oxidized/min/mg protein.
1.6. Assay of cystathionine-g-lyase
Cystathionine-g-lyase activity was measured in cytosol prepared from
mouse brain or liver according to Heinonen (1973). The reaction mixture (total
volume 0.5 ml) having cytosolic protein from liver (400 mg) or brain (2 mg),
100 ml Tris–HCl buffer (5 mM) and 10 ml of pyridoxal 50-phosphate (1 mM)
was considered as blank. The test sample contained all the above and 10 ml of L-
cystathionine (2 mM), which is the substrate. The samples were incubated for
2 h at 37 8C and the reaction was terminated by placing the tubes in ice-water
bath at 4 8C. DTT (5 mM, 10 ml) was added to each tube to reduce all cysteine.
Ninhydrin reagent was added to all the tubes and heated in boiling water bath for
10 min. Tubes were cooled under tap water, the absorbance of the pink coloured
complex was measured at 560 nm by spectrophotometric method (Gaitonde,
1967) using cysteine as standard.
1.7. Northern blotting
Whole brain and liver in case of mice, was homogenized in TRI reagent and
total RNA was extracted. mRNA was extracted from total RNA using mRNA
isolation kit purchased from Qiagen according to manufacturers protocol.
Amount of mRNA was quantitated and separated on agarose gel electrophor-
etically with total RNA. Then RNAwas transferred to positively charged nylon
membrane by capillary transfer UV cross-linked and hybridized with digox-
igenin labeled cRNA, which was prepared using cDNA. The blot was washed,
incubated with anti-digoxigenin antibody conjugated with alkaline phosphate
and visualized using a chromogenic substrate for alkaline phosphate.
1.8. In situ hybridisation
The paraffin sections from mouse and human brain regions were depar-
affinized by heating followed by treatment with xylene and chloroform. Then
sections were hydrated to facilitate action of proteinase K then again dehydrated
and hybridized with digoxigenin labelled cRNA synthesized by cDNA. After
hybridization the sections was washed and incubated with blocking reagent.
Antibody to digoxigenin conjugated to peroxidase was added after which
sections were treated with biotinylated tyramide followed by streptavidin–
fluorescein. The sections were observed under fluorescent microscope.
2. Results
2.1. Cystathionine g-lyase activity in mouse brain and liver
Cystathionine g-lyase activity was measured in cytosol
prepared from whole brain and liver of mice. The activity was
measured as rate of formation of cysteine using cytosolic
preparation from mouse brain and liver. The rate of formation
of cysteine increased with increasing protein concentration up
to 1.6 mg protein/ml of reaction mixture in brain. In liver,
where the activity was 100 fold higher than brain, the activity
was linear up to 0.4 mg protein/ml of reaction mixture (Fig. 1a).
Cystathionine g-lyase activity in mouse brain was only 1% of
the corresponding activity in liver.
2.2. Constitutive expression and localization of
cystathionine g-lyase in mouse liver and brain
The constitutive expression of cystathionine g-lyase mRNA
in mouse liver and brain was examined by northern blot
analysis. The (poly A+) RNA from mouse liver and brain wereelectrophoresed under denaturing conditions and transferred to
nylon membrane. The blot was hybridized using antisense
riboprobe synthesized using the cDNA of mouse liver
cystathionine g-lyase. A transcript of molecular mass of
approximately 1.7 kb was observed in mouse liver and brain
indicating the constitutive expression of cystathionine g-lyase
(Fig. 1b). Fluorescence in situ hybridisation (FISH) studies
demonstrated the presence of cystathionine g-lyase mRNA
predominantly in neuronal cells in mouse brain regions. The
neuronal cells in cerebral cortex showed intense cytosolic
staining, indicating the presence of cystathionine g-lyase
mRNA (Fig. 1c). The laminar architecture of different cortical
layers was clearly visible. In cerebellum, the Purkinje cells
showed intense fluorescence, while the granule cell layer was
relatively less intensely stained (Fig. 1c). Intense fluorescence
was seen in hippocampus, in the pyramidal neurons of CA2 and
CA3, and in the granule cell layer of dentate gyrus (Fig. 1c). In
midbrain, the reticular neurons were selectively labelled,
indicating predominant presence of cystathionine g-lyase
mRNA in these cell populations (Fig. 1c).
2.3. Effect of inhibition of cystathionine g-lyase on GSH
levels and mitochondrial complex I
Administration of L-propargylglycine (PPG) to rat increases
the serum cystathionine content by inhibiting cystathionine g-
lyase (Awata et al., 1984), while under normal condition
cystathionine is not found in the serum.We therefore, examined
the effect of PPG on brain cystathionine g-lyase activity and the
consequences of cystathionine g-lyase inhibition following
neurotoxic insult. A single dose of PPG (100 mg/kg body
weight) was administered to mice and cystathionine g-lyase
activity was estimated in brain after varying time periods. The
inhibition of cystathionine g-lyase activity by PPG in mice
brain leads to loss of GSH. Maximum GSH loss was seen at 6 h
(38%) and partial recovery was observed at 18 h (28% loss).
Decrease in GSH due to administration of PPG also leads to
inhibition complex I at 6 (30% inhibition) and 18 h (37%
inhibition; Fig. 2).
2.4. Effect of cystathionine g-lyase inhibition on
mitochondrial complex I loss mediated by L-BOAA
Earlier studies in our laboratory have shown that in male
mice a single dose of L-BOAA causes loss of GSH and
mitochondrial complex I in lumbosacral cord. This inhibition
can be reversed by DTT, in vitro, and by pretreatment of a-
lipoic acid in vivo, indicating that the inhibition is caused by
oxidation of critical thiol groups in complex I subunits (Sriram
et al., 1998; Kenchappa et al., 2002). We therefore, examined
the effect of cystathionine g-lyase inhibition on L-BOAA
mediated complex I dysfunction, since inhibition of cystathio-
nine g-lyase per se leads to loss of GSH and complex I.
Administration of L-BOAA or PPG alone caused similar effects
in terms of loss of GSH in lumbosacral cord. However,
administration of PPG followed L-BOAA induced greater GSH
loss (48% loss, Fig. 3a). In a similar manner, complex I loss was
Fig. 1. Constitutive expression of cystathionine g-lyase in mouse brain. (a) Effect of varying concentrations of protein on cystathionine g-lyase activity in cytosol
prepared from mouse brain and liver. The activity is expressed as nmoles of cysteine formed/h/mg protein. Values are mean  S.D. (n = 6 animals). (b) The mRNA
and total RNA from mouse liver and brain were electrophoresed under denaturing conditions. After transfer to nylon membrane, the blot was hybridized with ribo-
probe prepared using cDNA from mouse liver cystathionine g-lyase. Lanes 1 and 2 were loaded with 5 mg of (poly A+) RNA from liver and brain, respectively. (c)
Presence of cystathionine g-lyase in the neurons of cerebral cortex (A; bar = 50 mm). Inset: magnified view of a cortical neuron. Fluorescent labeling of the Purkinje
cells in the mouse cerebellum is depicted (B; bar = 50 mm). Inset: magnified view of the Purkinje cell in cerebellum. Fluorescence labeling was seen in granule cell
layer of dentate gyrus. The CA2, and CA3 subfields of the hippocampus were intensely fluorescent (C; bar = 200 mm). Inset: magnified view of the pyramidal neuron
in hippocampus. (D) Intense fluorescence was seen in reticular neurons in the midbrain which express cystathionine g-lyase mRNA (bar = 50 mm). Inset: magnified
view of a reticular neuron of midbrain.
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than when given alone (Fig. 3a).
2.5. DTT reverses complex I inhibition caused due to
pretreatment of L-propargylglycine followed by L-BOAA
Earlier studies from our laboratory had shown that complex I
inhibition caused by L-BOAA can be reversed by treating
isolated mitochondria with the disulfide reductant, dithiothrei-
tol (DTT; Sriram et al., 1998). We therefore, examined if
similar reversal could take place in PPG treated mice. Mice
were pretreated with PPG (100 mg/kg body weight, s.c.) for 6 h
followed by L-BOAA (10 mg/kg body weight, s.c.) for 1 h and
mitochondria was isolated from lumbosacral cord. The
inhibition of complex I caused by PPG alone or PPG and L-
BOAA was reversed by DTT (Fig. 3b) indicating that the
inhibition is caused by oxidation of critical thiols of complex I
subunits. These results reiterated that maintenance of thiol
status is important for complex I activity and its recovery after
neurotoxic insult.2.6. Prolonged exposure to L-BOAA inhibits cystathionine
g-lyase activity in mouse brain and spinal cord
A single dose of L-BOAA (10 mg/kg body weight, s.c.) was
administered to mice and they were sacrificed at 1 and 30 h.
Later, cystathionine g-lyase activity was measured in cytosol
prepared from brain and spinal cord. L-BOAA inhibited the
activity of cystathionine g-lyase in brain (35%) and spinal cord
(40%) at 30 h, while it had no effect after 1 h exposure (Fig. 4a).
These results suggested that cystathionine g-lyase is not
affected at early intervals after L-BOAA, but exposure for
longer periods inhibits cystathionine g-lyase activity.
2.7. Cystathionine g-lyase inhibition caused by L-BOAA
was not reversed by DTT
A single dose of L-BOAA (10 mg/kg body weight) was
administered to mice and sacrificed after 30 h. Cytosol prepared
from whole brain and spinal cord was incubated with and
without DTT for 1 h at 37 8C. The resin was removed by brief
Fig. 2. Effect of L-propargylglycine (PPG) on the activity of cystathionase g-
lyase, complex I and GSH levels in mice brain. PPG (100 mg/kg body weight,
s.c) was administered to mice and animals were killed at 6 and 18 h after dosage
(gray bar). Control animals received vehicle alone (black bar). Complex I and
cystathionine g-lyase activities and GSH levels were estimated in whole brain
of mice. The activity of complex I is expressed as nmoles of NADH/min/mg
protein. cystathionine g-lyase activity is expressed as nmoles of cysteine/h/mg
protein and GSH levels are expressed as nmoles of GSH/mg protein. Values are
mean  S.E.M. (n = 6 animals). Asterisks indicate values significantly different
from controls (P < 0.002).
L. Diwakar, V. Ravindranath / Neurochemistry International 50 (2007) 418–426422centrifugation and cystathionine g-lyase activity was measured
in the cytosol. DTT did not reverse the inhibition of
cystathionine g-lyase caused by L-BOAA (Fig. 4b).
2.8. Pretreatment of a-lipoic acid protects against
inhibition of cystathionine g-lyase and complex I activity by
L-BOAA
Mice were pretreated 1 h before with a-lipoic acid (20 mg/
kg body weight, s.c.) followed by L-BOAA and sacrificed after
30 h and complex I activity was measured in motor cortex and
lumbosacral cord. L-BOAA causes loss of complex I activity in
motor cortex and lumbosacral cord. However, pretreatmentwith a-lipoic acid prevented loss of complex I activity
following L-BOAA treatment for 30 h (data not shown). These
results suggest that maintenance of thiol homeostasis is
important to ensure mitochondrial function. Cystathionine g-
lyase activity was also measured in brain and spinal cord
following treatment of animals with a-lipoic acid and L-BOAA.
Prolonged exposure to L-BOAA caused loss of cystathionine g-
lyase activity in brain and spinal cord. However, when mice
were pretreated with a-lipoic acid the loss of cystathionine g-
lyase was prevented (Fig. 4c).
2.9. Constitutive expression and localization of
cystathionine g-lyase in human brain
Cystathionine g-lyase activity was measured in cytosol
prepared from human brain regions obtained at autopsy from
traffic accident victims. No significant difference was observed
in cystathionine g-lyase activity amongst brain regions such as
cortex, cerebellum, striatum, thalamus and pons except in
hippocampus where the activity was significantly lower (36%;
Fig. 5a). Cystathionine g-lyase activity in human brain was
100-fold higher than that observed in mouse brain (Fig. 5).
The (poly A+) RNA isolated from human brain was
electrophoresed under denaturing conditions and transferred to
a nylon membrane. The blot was hybridised using the antisense
riboprobe synthesised using cDNA of cystathionine g-lyase
from mouse liver, which has 90% homology with human liver
cDNA. The northern blot analysis revealed the presence of
cystathionine g-lyase transcript with molecular weight of
approximately 1.7 kb (Fig. 5b).
In order to localize cystathionine g-lyase mRNA in human
brain regions, fluorescence in situ experiment was performed
using paraffin-embedded human brain section. Fluorescence in
situ hybridisation (FISH) studies demonstrated the presence of
cystathionine g-lyase mRNA predominantly in neuronal cells
in human brain regions (Fig. 5c). Cystathionine g-lyase mRNA
was seen in the neurons in cerebral cortex. In the cerebellum,
Purkinje cells showed intense fluorescence, while the granule
cell layer was less intensely stained. Intense fluorescence was
observed in the granule cell layer in the dentate gyrus and CA3
pyramidal neurons in the hippocampus. The reticular neurons
in the midbrain were also stained indicating the presence of
cystathionine g-lyase mRNA in these cell populations.
3. Discussion
Cystathionine g-lyase activity in mouse brain was very low
and represented 1% of the hepatic activity. However, significant
amount of cystathionine g-lyase activity was detectable in
human brain. In fact, the activity was 100 times more than the
corresponding activity in mouse brain. Such differences have
not been noted in the activity of g-glutamyl cysteinyl synthase,
the rate-limiting enzyme in GSH synthesis or in GSH levels per
se between human and mouse brain (Mirecki et al., 2004;
Schulz et al., 2000). It is presumable that cystathionine g-lyase
plays an important role in human brain. The enzyme activity
was similar in most regions of the brain, except in hippocampus
Fig. 3. Effect of L-propargylglycine pretreatment on L-BOAA toxicity and its reversal by thiol reductant. (a) Mice were pretreated for 6 h with L-propargylglycine
(100 mg/kg body weight, s.c.) prior to administration of L-BOAA (10 mg/kg body weight, s.c.) and sacrificed 1 h after L-BOAA dose. Control animals received
vehicle alone. GSH and complex I activity were estimated in lumbosacral cord. The values are expressed as nmoles of GSH/mg protein and nmoles of NADH
oxidized/min/mg protein, respectively. Values are mean  S.E.M. (n = 6 animals). Asterisks indicate values significantly different from controls (P < 0.002). (b)
Mitochondria were isolated from lumbosacral cord of mice pretreated with 6 h of L-propargylglycine (100 mg/kg body weight, s.c.) followed L-BOAA (10 mg/kg
body weight, s.c.) for 1 h. Mitochondrial samples were incubated with (+DTT) and without (DTT) for 30 min at 37 8C. The loss of complex I activity was reversed
by dithiothreitol indicating that oxidation of sulphydryl was responsible for the inhibition. Complex I activity is expressed as nmoles of NADH/min/mg protein.
Values are depicted as mean  S.D. (n = 4 animals). Asterisks indicate values significantly different from controls (P < 0.002).
Fig. 4. Effect of L-BOAA on cystathionine g-lyase activity in mouse brain and spinal cord. (a) Animals were dosed with L-BOAA (10 mg/kg body weight, s.c.) and
sacrificed at 1 and 30 h later. Cystathionine g-lyase activity was measured in brain and spinal cord. Values are mean  S.D. (n = 6 animals) and asterisks indicate
values significantly different from vehicle treated controls (P < 0.002). (b) Cytosol isolated from brain and spinal cord of mice treated with vehicle or L-BOAA
(10 mg/kg body weight, s.c.) for 30 h were incubated with (+DTT) and without (DTT) for 30 min at 37 8C. Cystathionine g-lyase activity was measured. Data are
depicted as mean  S.D. (n = 4 animals). Asterisks indicate values significantly different from controls (P < 0.002). (c) Animals were pretreated with a-lipoic acid
(20 mg/kg body weight, s.c.) 1 h prior to administration of L-BOAA (10 mg/kg body weight, s.c.) and sacrificed 30 h after the L-BOAA dose. Activity of cystathionine
g-lyase was measured in the brain and spinal cord. Values are mean  S.D. (n = 6 animals) and asterisks indicate values significantly different from vehicle treated
controls (P < 0.002).
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Fig. 5. Cystathionine g-lyase activity and expression in human brain regions. (a) Activity of cystathionine g-lyase was estimated in cytosol prepared from human
brain regions and is expressed as nmoles of cysteine formed/h/mg protein. The brain regions are represented as: CT, cortex; CE, cerebellum; ST, striatum; TH,
thalamus; PO, pons; HP, hippocampus. Data are mean  S.E.M. values (n = 6 human brain samples). Asterisks indicate values significantly different from cortex
(P < 0.05). (b) Human brain mRNA (5 mg) and total RNA was electrophoresed under denaturing conditions. After transfer to nylon membrane, the blot was
hybridized with ribo-probe prepared using cDNA from mouse liver cystathionine g-lyase. The cystathionine g-lyase mRNA was seen as a band at approximately
1.7 kb in human brain cortex. (c) Intense fluorescence was seen in the neuronal cell layers of the human brain cortex (A; bar = 200 mm). Inset: magnified view of a
cortical neuron. Fluorescent labeling of the Purkinje cells and the granule cell layer was seen in the human cerebellum (B; bar = 100 mm). Inset: magnified view of
Purkinje cells of cerebellum. The presence of cystathionine g-lyase mRNAwas seen in the pyramidal neurons of CA3 and and granule cell layer of dentate gyrus (C;
bar = 100 mm). Inset: magnified view of a pyramidal neuron of hippocampus. Reticular neurons in the midbrain express cystathionine g-lyase mRNA (D;
bar = 100 mm). Inset: magnified view of a reticular neuron in midbrain.
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This is the first report of the presence of cystathionine g-lyase
activity in human brain. It is known that the activity in human
liver is about 28 mU/mg protein and in AIDS patients the
activity was substantially reduced, which has been causally
related to low levels of plasma glutathione in AIDS patients
(Martin et al., 2001). The impairment in the enzyme activity
results in the accumulation of cystathionine leading to
cystathionuria, which causes mental retardation in human
brain (Vina et al., 1995).
The expression of cystathionine g-lyase in all regions of
mouse and human brain as observed by in situ hybridization
showed predominant localization in neuronal population. PPG
(a specific inhibitor) was able to inhibit cystathionine g-lyase,
which resulted in loss of GSH indicating that availability of
adequate amount of cysteine is important for maintenance of
GSH level in the CNS. The loss of GSH in CNS caused by PPG
administration could be exploited to generate in vivo models of
GSH depletion since L-buthionine sulfoxamine (an inhibitor of
g-glutamyl cysteine synthase), which is often used to deplete
GSH does not cross the blood brain barrier.
Inhibition of cystathionine g-lyase results in loss of GSH
which precedes complex I inhibition. It is debatable if the
decrease in complex I activity is caused due to GSH loss, per se,
or if it is an indirect effect of reactive oxygen species, such as
superoxide and hydrogen peroxide that are generated as a
consequence of GSH depletion. This potentially causes
oxidative modification of proteins, such as carbonylation andnitrosolylation, which are not reversible by disulphide
reductants. The complex I dysfunction seen in the present
study is predominantly due to reversible disulphide formation
since the activity can be recovered, in vitro, by reducing agents
such as dithiothreitol. Our earlier studies have shown that loss
of GSH in brain results in extensive glutathionylation of
proteins (Ravindranath and Reed, 1990) and glutathionylation
of critical thiol groups in the 52 and 75 kDa subunits of
complex I results in loss of complex I activity (Taylor et al.,
2003). This probably underlies the complex I dysfunction seen
after PPG exposure. Previous studies have shown that exposure
of isolated mitochondria to acrolein results in dose dependent
increase in reactive oxygen species (ROS) and decrease in GSH
levels (Luo and Shi, 2005), which is accompanied by
mitochondrial permeability transition. Further, mitochondrial
dysfunction caused by increased ROS leads to necrosis and
such mechanisms may play a role in neurodegenerative
disorders (Luo et al., 2005).
A study in frog (Rana temporaria) brain in the course of the
fall migration to wintering sites and the period of hibernation,
has shown that there is diminished level of GSH in the brain,
which correlates with the changes observed in the activity of
cystathionine g-lyase and other enzymes for cysteine delivery.
In addition, diminished mitochondria-related oxidative meta-
bolism was also observed (Wrobel, 2001). Thus, cystathionine
g-lyase is important for GSH synthesis which in turn regulates
thiol status of enzymes like complex I, which are important for
mitochondrial function.
Fig. 6. Influence of cystathionine g-lyase activity on glutathione levels and
complex I activity. Transsulfuration pathway is the main source for cysteine
derived from dietary methionine. ATP-dependent activation of methionine leads
to the production of S-adenosylmethionine (catalyzed by methionine adenosyl-
transferase), and subsequent demethylation and removal of the adenosyl moiety
yields homocysteine. Homocysteine condenses with serine to form cystathio-
nine in a reaction catalyzed by cystathionine b-synthase (using pyridoxal 50
phosphate as cofactor). Cystathionine g-lyase (a pyridoxal 50 phosphate depen-
dent enzyme) is the regulatory enzyme in the synthesis of cysteine. It catalyzes
the conversion of L-cystathionine into L-cysteine, a-ketobutyrate and ammonia.
Inhibition of cystathionine g-lyase by L-propargyl glycine causes loss of
glutathione due to decrease in cysteine availability. Decreased glutathione
level results in glutathionylation of proteins leading to formation of protein
glutathione mixed disulfides. This results in inhibition of enzymes, which have
thiol groups in their active site, such as complex I.
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exacerbates the excitotoxicity caused by L-BOAA. The additive
effect resulted in greater GSH loss and complex I inhibition.
The inhibition of mitochondrial complex I by PPG and L-
BOAA in lumbosacral cord can be reversed by thiol reductant
DTT (dithothreitol) showing that the loss of complex I activity
was due to thiol oxidation. Although cystathionine g-lyase
activity is low in brain, its inhibition leads to thiol oxidation and
complex I inhibition indicating a causal link between cysteine
synthesis, GSH availability and mitochondrial function.
Increased production of ROS by mitochondria is a major
contributor to oxidative damage seen inmany neurodegenerative
disorders. Complex I is the largest component of respiratory
chain and a major source of reactive oxygen species. There is
selective loss of complex I function in certain neurodegenerative
disorders, such as, Parkinson’s disease (Schulz et al., 2000).
Earlier studies from our lab have demonstrated that alterations in
glutathione pool inhibits complex I function (Balijepalli et al.,
1999), which can be reversed in vitro by the disulfide reductant,
dithothreitol and in vivo by pretreatment with a-lipoic acid,
indicating that inhibition occurs through oxidation of critical
thiol groups in complex I subunits (Sriram et al., 1998;
Kenchappa et al., 2002).The excitatory amino acid L-BOAA, per se, inhibited
cystathionine g-lyase activity 30 h after the initial exposure
(Fig. 4a), indicating that the enzyme itself is susceptible to
inactivation by the oxidative stress generated by the excitatory
amino acid. We then ascertained if the inhibition was due to
reversible oxidation of cysteine residues in the enzyme, which
can then be reversed by DTT, in vitro. Inhibition of cystathionine
g-lyase caused by L-BOAAwas not reversible by DTT (Fig. 4b)
indicating that the inhibition was not due to reversible oxidation
of cysteine residues to disulphides. Prior treatment with a-lipoic
acid, a thiol antioxidant prevented oxidative modification of
cystathionineg-lyase caused by L-BOAA(Fig. 4c). These studies
suggest that maintenance of protein thiol homeostasis is not only
important for mitochondrial function but also for enzymes
involved in GSH synthesis. The inhibition of cystathionine g-
lyase by L-BOAAmay explain the sustained loss of GSH seen in
the lumbar spinal cord following L-BOAA (Sriram et al., 1998).
Cystathionine g-lyase mRNA was localized in brain and
found to be present predominantly in neuronal cells in mouse
brain indicating the potential role of the enzyme in synthesis of
cysteine in neuronal cells. The other source of cysteine, which
is the sodium dependent transporter(s) for cysteine, has been
reported in cultured neurons and glia (Bannai, 1986). However,
it remains to be elucidated whether such transporter exists in
brain and if so, their role in transport of cysteine in neuronal
cells needs to be defined.
In conclusion, cystathionine g-lyase is important for
maintaining GSH levels in brain, which in turn is critical for
mitochondrial function. Dysfunction of cystathionine g-lyase
results in mitochondrial dysfunction due to oxidative modifica-
tion of complex I subunits (Fig. 6). Importantly, cystathionine
g-lyase can be inactivated by oxidative stress, which can have
far-reaching implication in terms of aggravating oxidative
damage and limiting the recovery.
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